ITGA5 and non-small cell lung carcinoma: To assess whether ITGA5 was implicated in GALNT2-mediated malignant phenotypes of NSCLC cells, we silenced ITGA5 expression with siRNA in GALNT2-overexpressing cells (Fig. 7E).